{
    "clinical_study": {
        "@rank": "33296", 
        "acronym": "PHARM-CHF", 
        "arm_group": [
            {
                "arm_group_label": "regular, pharmacy-based intervention", 
                "arm_group_type": "Experimental", 
                "description": "providing medication in weekly dosing aids and regular contacts with the local pharmacy"
            }, 
            {
                "arm_group_label": "usual care", 
                "arm_group_type": "No Intervention", 
                "description": "usual care"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to investigate, whether a continuous interdisciplinary intervention\n      leads to a reduction of hospitalizations and mortality in elderly patients with chronic\n      heart failure. The intervention, consisting of regular contacts with the local pharmacy and\n      weekly dosing aids, aims to improve medication adherence and management."
        }, 
        "brief_title": "Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 60 years and older\n\n          -  Chronic heart failure (CHF)\n\n          -  Stable CHF medication including a diuretic\n\n          -  Hospitalization for decompensated heart failure within past 12 months OR a value of \u2265\n             350 pg/mL for BNP or \u2265 1,400 pg/mL for NT-proBNP\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Use of a weekly dosing aid\n\n          -  Unwillingness or inability to visit a participating pharmacy once a week\n\n          -  Planned cardiac surgery\n\n          -  Life-expectancy < 6 months\n\n          -  Unwillingness or inability to comply with the study protocol (including drug abuse or\n             alcohol dependency)\n\n          -  Participation in other studies (currently or in the last 3 months)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "2060", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01692119", 
            "org_study_id": "PHARM-CHF"
        }, 
        "intervention": {
            "arm_group_label": "regular, pharmacy-based intervention", 
            "description": "Regular, pharmacy-based intervention conducted in cooperation with the treating physician:\nMedication review at baseline: recording of all medicines currently taken (prescribed medication and self-medication), check for drug-related problems, consolidation of a medication plan.\nRegularly (weekly): dose-dispensing of the medication (weekly dosing aid), discussion and counseling regarding medication, adherence, potential side effects, and signs and symptoms of cardiac decompensation; blood pressure and pulse measurement. If required: contact with patients' physician.", 
            "intervention_name": "Regular, pharmacy based intervention", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "chronic heart failure", 
            "medication adherence", 
            "pharmacy", 
            "interdisciplinary care", 
            "randomized controlled trial", 
            "mortality", 
            "hospitalization"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "link": {
            "description": "PHARM-CHF study home page", 
            "url": "http://www.pharm-chf.de"
        }, 
        "location": {
            "contact": {
                "email": "pharm.chf@uks.eu", 
                "last_name": "Ulrich Laufs, Prof. MD", 
                "phone": "+49 (0)6841-162", 
                "phone_ext": "3412"
            }, 
            "facility": {
                "address": {
                    "city": "Homburg/Saar", 
                    "country": "Germany", 
                    "zip": "66421"
                }, 
                "name": "Saarland University"
            }, 
            "investigator": {
                "last_name": "Ulrich Laufs, Prof. MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure (PHARM-CHF): A Randomized Controlled Trial", 
        "overall_contact": {
            "email": "arzneimittel@abda.aponet.de", 
            "last_name": "Martin Schulz, Prof. PhD", 
            "phone": "+49 (0) 30 40004", 
            "phone_ext": "511"
        }, 
        "overall_contact_backup": {
            "email": "pharm.chf@uks.eu", 
            "last_name": "Ulrich Laufs, Prof. MD", 
            "phone": "+49 (0) 6841 162", 
            "phone_ext": "3412"
        }, 
        "overall_official": [
            {
                "affiliation": "Federal Union of German Associations of Pharmacists", 
                "last_name": "Martin Schulz, Prof. PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Saarland University", 
                "last_name": "Ulrich Laufs, Prof. MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "composite, recurrent event, number", 
            "measure": "All-cause mortality or unplanned cardiovascular hospitalizations", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for an expected average of 21 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01692119"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Federal Union of German Associations of Pharmacists", 
        "sponsors": {
            "collaborator": {
                "agency": "Saarland University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Federal Union of German Associations of Pharmacists", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}